Clinical relevance of the borderline results of the Hybrid Capture 2 High-Risk HPV DNA assay with cervical samples collected in Specimen Transport Medium
Authors
Jerneja Varl
Department of Experimental Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
University of Ljubljana, Faculty of Medicine, Ljubljana, Slovenia
Urska Ivanus
ZORA National Cervical Cancer Screening Programme, Epidemiology and Cancer Registry, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Ziva Pohar Marinsek
Department of Cytopathology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Tine Jerman
ZORA National Cervical Cancer Screening Programme, Epidemiology and Cancer Registry, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Anja Ostrbenk Valencak
Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Mario Poljak
Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Veronika Kloboves Prevodnik
Department of Cytopathology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Language: English
Page range: 316 - 322
Submitted on: Jul 10, 2019
Accepted on: Aug 6, 2019
Published on: Sep 24, 2019
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2019 Jerneja Varl, Urska Ivanus, Ziva Pohar Marinsek, Tine Jerman, Anja Ostrbenk Valencak, Mario Poljak, Veronika Kloboves Prevodnik, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.